Atrium Therapeutics, Inc. (RNA)
7.84
-0.30
(-3.69%)
USD |
NASDAQ |
Oct 02, 16:00
7.98
+0.14
(+1.79%)
Pre-Market: 20:00
Atrium Therapeutics Profit Margin (Quarterly) : -672.0% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -672.0% |
| March 31, 2026 | -84.71% |
| December 31, 2025 | -3.39K% |
| Date | Value |
|---|---|
| June 30, 2025 | -334.8% |
| March 31, 2025 | -473.6% |
| December 31, 2024 | -387.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -10.44K% |
| Celularity, Inc. | 17.55% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.28% |
| Return on Assets | -40.65% |
| Return on Invested Capital | -60.03% |
| Gross Profit Margin (Quarterly) | 88.58% |
| Operating Margin (Quarterly) | -752.9% |
| Return on Net Operating Assets | -578.8% |